The Professor, who is the the Dean of Faculty of Population Health Sciences at University College London, received the sum of $100,000 for the win. The award ceremony was held on October 12.
Now in its 10th year, the Roux Prize has been recognizing individuals all over the globe who have leveraged evidence-based health data to improve population health. The Roux Prize is awarded by the Institute for Health Metrics and Evaluation (IHME) at the

University of Washington’s School of Medicine.
According to Roux Prize, Professor Abubakar has been steadfast in his contributions to global health.
“His expertise and advocacy have directly affected policy implementation and the lives of millions of people.”

Professor Abubakar also led an international multidisciplinary team in March 2022, and completed a comprehensive analysis of Nigeria’s health system supported by Global Burden of Disease (GBD) data.
The research identified critical gaps and offered recommendations in key areas to improve health care staffing, information systems, and access to care for all Nigerians.
Professor Ibrahim Abubakar had said: “What drives me each day is the firm belief that the existence of health inequalities is not a given – it is within our reach to eliminate inequitable access to care if we work collectively to improve the lives and conditions of the most disadvantaged among us.”

Professor Abubakar’s determination in pushing for fairness comes from his father, who was born in Nigeria’s Bauchi State His father lived under British colonial occupation amidst debilitating poverty but was able to get an education and build a career as a civil servant. As a child, Professor Abubakar saw the social and economic disparities in his home country through his father’s work. As an adult, Professor Abubakar chose to study medicine in northern Nigeria to address the health inequities.
“My career veered to population health after witnessing the ravaging effect of HIV and other infections on my patients.

“As a young doctor, I distinctly remember patients arriving in my ward and dying of a preventable form of meningitis. Most of these patients were too poor and had been failed by society,” said Professor Abubakar.
“I believe my subsequent achievements and persistent commitment to medicine and public health had a lot to do with the contrast I have seen all my life: what is possible with levels of opportunity and wealth and the unfairness of outcomes.”

Prof. Abubakar has been instrumental in the development of health initiatives for tuberculosis (TB) and COVID-19.
As the head of TB in Public Health England in 2015, he developed a research program that improved screenings. Prof. Abubakar also chaired committees, such as the WHO Strategic Advisory Group for TB, that led to better diagnoses and increased access to treatment, contributing to a 2% annual decline in new TB cases globally from 2015 to 2018.

In 2020, Professor Abubakar was appointed as Scientific and Technical Adviser to the Nigeria Presidential Taskforce on COVID-19. He organized a team that responded to daily requests for evidence, aided in developing the type and timing of national COVID-19 restrictions, and wrote over 40 policy papers that ultimately served as a national vaccination policy. He is also leading an international study on COVID-19 variants, which includes cohorts from Europe, South America, Africa, and Asia.
“I feel lucky that my career and role allow me to have the privileges of working in a top university in the UK and impacting health policy in my adopted country, while being able to contribute to the generation of evidence that influences global health and health policy in Africa and Nigeria specifically,” said Professor Abubakar.
As the Roux Prize winner, Professor Abubakar received a $100,000 award to reinforce his efforts to support health systems in Nigeria and Africa’s Sahel region, benefitting some of the world’s poorest countries, among other significant global health programs.